Advertisement
Advertisement

EQ

EQ logo

Equillium, Inc. Common Stock

1.43
USD
Sponsored
+0.05
+3.26%
Jan 30, 15:59 UTC -5
Closed
exchange

After-Market

1.41

-0.01
-0.77%

EQ Earnings Reports

Positive Surprise Ratio

EQ beat 20 of 29 last estimates.

69%

Next Report

Date of Next Report
Mar 25, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$0.05
Implied change from Q3 25 (Revenue/ EPS)
--
/
-16.67%
Implied change from Q4 24 (Revenue/ EPS)
-100.00%
/
-68.75%

Equillium, Inc. Common Stock earnings per share and revenue

On Nov 13, 2025, EQ reported earnings of -0.06 USD per share (EPS) for Q3 25, beating the estimate of -0.14 USD, resulting in a 59.81% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +23.81% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analysts forecast an EPS of -0.05 USD, with revenue projected to reach -- USD, implying an decrease of -16.67% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nurix Therapeutics, Inc. Common stock
Report Date
Jan 28, 2026 For Q4 25
Estimate
-$0.88
Actual
-$0.82
Surprise
+7.66%
logo
Regeneron Pharmaceuticals Inc
Report Date
Jan 30, 2026 For Q4 25
Estimate
$10.84
Actual
$11.44
Surprise
+5.52%
FAQ
For Q3 2025, Equillium, Inc. Common Stock reported EPS of -$0.06, beating estimates by 59.81%, and revenue of $0.00, 0% as expectations.
The stock price moved up 23.81%, changed from $0.84 before the earnings release to $1.04 the day after.
The next earning report is scheduled for Mar 25, 2026.
Based on 4 analysts, Equillium, Inc. Common Stock is expected to report EPS of -$0.05 and revenue of -- for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement